The GENPLEX™ Multiplex RT-PCR Test is a cutting-edge, real-time reverse transcription polymerase chain reaction assay designed for the simultaneous detection of multiple pathogens or gene targets in a single reaction. Leveraging advanced multiplexing technology, this assay enables high-throughput, cost-effective, and accurate diagnostics across infectious diseases, respiratory panels, sexually transmitted infections, and more.
The GENPLEX™ Multiplex RT-PCR Test is a cutting-edge, real-time reverse transcription polymerase chain reaction (RT-PCR) assay designed for the simultaneous detection of multiple pathogens or gene targets in a single reaction. Leveraging multiplexing technology, this assay enables high-throughput, cost-effective, and accurate diagnostics — essential for infectious diseases, respiratory panels, sexually transmitted infections, and more.
Whether used in clinical diagnostics, epidemiological surveillance, or public health programs, the GENPLEX™ Multiplex RT-PCR Test offers robust performance with high sensitivity and specificity, significantly reducing time-to-result and maximizing lab efficiency.
Manufactured under ISO 13485 certified quality standards, GENPLEX™ assays are validated on major RT-PCR platforms with both lyophilized and ready-to-use master mix formats available.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
Identify multiple pathogens or gene targets simultaneously in a single PCR reaction, reducing cost and turnaround time.
Sensitivity ≥95% and specificity ≥98% across diverse pathogen panels, ensuring reliable diagnostic accuracy.
Results typically available within 90–120 minutes — enabling timely clinical decision-making.
Validated for use on all major qPCR instruments — no proprietary hardware requirement.
Positive, negative, and internal controls included in every run to ensure result integrity.
Manufactured under ISO 13485 certified processes with lyophilized and ready-to-use formats available.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Simultaneous detection of SARS-CoV-2, Influenza A/B, RSV, and other respiratory pathogens in a single assay.
Comprehensive detection of bacterial, viral, and parasitic GI pathogens from stool specimens.
Rapid identification of pathogens causing systemic infections with antimicrobial resistance gene detection.
Multiplex detection of key STI pathogens including Chlamydia, Gonorrhea, and other organisms.
Identification of resistance genes (AMR markers) alongside pathogen detection for guided antibiotic therapy.
Detection of clinically relevant genetic variants for pharmacogenomics, oncology, and disease risk assessment.
| Parameter | Value / Description |
|---|---|
| Assay Type | Multiplex Real-Time RT-PCR |
| Targets per Assay | Up to 4–8 (customizable per panel) |
| Sample Types | Nasopharyngeal swabs, plasma, urine, stool, and more |
| Time to Result | 90–120 minutes |
| Sensitivity | ≥ 95% |
| Specificity | ≥ 98% |
| Controls Included | Positive, negative, and internal control |
| Storage | -20°C (long-term), 2–8°C (short-term) |
| Quality Standard | ISO 13485 Certified Manufacturing |
| Instrument Compatibility | All major qPCR platforms |
| Intended Use | In Vitro Diagnostic (IVD) |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| GENPLEX™ Multiplex RT-PCR Kit (contact for specific panel) | Contact Us | 48 / 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products